574 related articles for article (PubMed ID: 29383422)
1. Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease.
Yu H; Wang D; Zou L; Zhang Z; Xu H; Zhu F; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Yang X
Arch Toxicol; 2018 Apr; 92(4):1363-1382. PubMed ID: 29383422
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal Subcellular Organelle Proteomic Alteration of Copper-Treated Mice.
Yu H; Jiang X; Lin X; Zhang Z; Wu D; Zhou L; Liu J; Yang X
Toxicol Sci; 2018 Jul; 164(1):250-263. PubMed ID: 29617964
[TBL] [Abstract][Full Text] [Related]
3. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease.
Yu H; Lin X; Wang D; Zhang Z; Guo Y; Ren X; Xu B; Yuan J; Liu J; Spencer PS; Wang JZ; Yang X
Front Mol Neurosci; 2018; 11():74. PubMed ID: 29593495
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Key Molecules Involved in Spatial Memory Impairment in Triple Transgenic Mice of Alzheimer's Disease.
Ying M; Sui X; Zhang Y; Sun Q; Qu Z; Luo X; Chang RC; Ni J; Liu J; Yang X
Mol Neurobiol; 2017 Jul; 54(5):3843-3858. PubMed ID: 27335030
[TBL] [Abstract][Full Text] [Related]
6. Low-dose oral copper treatment changes the hippocampal phosphoproteomic profile and perturbs mitochondrial function in a mouse model of Alzheimer's disease.
Chen C; Jiang X; Li Y; Yu H; Li S; Zhang Z; Xu H; Yang Y; Liu G; Zhu F; Ren X; Zou L; Xu B; Liu J; Spencer PS; Yang X
Free Radic Biol Med; 2019 May; 135():144-156. PubMed ID: 30862541
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers.
Carvalho C; Santos MS; Oliveira CR; Moreira PI
Biochim Biophys Acta; 2015 Aug; 1852(8):1665-75. PubMed ID: 25960150
[TBL] [Abstract][Full Text] [Related]
8. Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.
Chou JL; Shenoy DV; Thomas N; Choudhary PK; Laferla FM; Goodman SR; Breen GA
J Proteomics; 2011 Apr; 74(4):466-79. PubMed ID: 21237293
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
[TBL] [Abstract][Full Text] [Related]
10. Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.
Stojakovic A; Chang SY; Nesbitt J; Pichurin NP; Ostroot MA; Aikawa T; Kanekiyo T; Trushina E
J Alzheimers Dis; 2021; 79(1):335-353. PubMed ID: 33285637
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal Proteomic Alteration in Triple Transgenic Mouse Model of Alzheimer's Disease and Implication of PINK 1 Regulation in Donepezil Treatment.
Zhou X; Xiao W; Su Z; Cheng J; Zheng C; Zhang Z; Wang Y; Wang L; Xu B; Li S; Yang X; Pui Man Hoi M
J Proteome Res; 2019 Apr; 18(4):1542-1552. PubMed ID: 30484658
[TBL] [Abstract][Full Text] [Related]
12. Melatonin ameliorates anxiety and depression-like behaviors and modulates proteomic changes in triple transgenic mice of Alzheimer's disease.
Nie L; Wei G; Peng S; Qu Z; Yang Y; Yang Q; Huang X; Liu J; Zhuang Z; Yang X
Biofactors; 2017 Jul; 43(4):593-611. PubMed ID: 28608594
[TBL] [Abstract][Full Text] [Related]
13. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ
Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial proteomic alterations caused by long-term low-dose copper exposure in mouse cortex.
Lin X; Wei G; Huang Z; Qu Z; Huang X; Xu H; Liu J; Zhuang Z; Yang X
Toxicol Lett; 2016 Nov; 263():16-25. PubMed ID: 27769873
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease.
Nie L; Xia J; Li H; Zhang Z; Yang Y; Huang X; He Z; Liu J; Yang X
Oxid Med Cell Longev; 2017; 2017():6473506. PubMed ID: 29204248
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Dysfunction in Neocortex and Hippocampus of Olfactory Bulbectomized Mice, a Model of Alzheimer's Disease.
Avetisyan AV; Samokhin AN; Alexandrova IY; Zinovkin RA; Simonyan RA; Bobkova NV
Biochemistry (Mosc); 2016 Jun; 81(6):615-23. PubMed ID: 27301290
[TBL] [Abstract][Full Text] [Related]
17. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
[TBL] [Abstract][Full Text] [Related]
18. Tetramethylpyrazine Improves Cognitive Impairment and Modifies the Hippocampal Proteome in Two Mouse Models of Alzheimer's Disease.
Huang X; Yang J; Huang X; Zhang Z; Liu J; Zou L; Yang X
Front Cell Dev Biol; 2021; 9():632843. PubMed ID: 33791294
[TBL] [Abstract][Full Text] [Related]
19. Proteomic Profiles of the Early Mitochondrial Changes in APP/PS1 and ApoE4 Transgenic Mice Models of Alzheimer's Disease.
He K; Nie L; Zhou Q; Rahman SU; Liu J; Yang X; Li S
J Proteome Res; 2019 Jun; 18(6):2632-2642. PubMed ID: 31055927
[TBL] [Abstract][Full Text] [Related]
20. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
